serotonin transporter polymorphism (5-httlpr) and citalopram effectiveness in iranian patients with major depressive disorder.
نویسندگان
چکیده
objective: several studies have implicated the 5-httlpr polymorphism in treatment outcomes of selective serotonin re-uptake inhibitors in patients with major depression. the aim of this study was to examine the association between polymorphism in the serotonin transporter gene and citalopram effectiveness in iranian patients suffering from major depressive disorder (mdd). methods: the sample consisted of 104 patients, with fars ethnic background, who were diagnosed according to dsm-iv-tr criteria. beck depression inventory was used to evaluate the severity of the symptoms during the follow-up, and to determine clinical response of the patients at 4th and 8th week, respectively. results: our results showed a correlation between the genotype and response to antidepressant drug citalopram, (odds ratios for l/s and l/l were 3.90 (95 percent ci: 1.29- 11.80) and 1.90 (95 percent ci: 0.72-5.08), respectively). conclusion: in conclusion, our results reveal that genetic variation of serotonin transporter is involved in clinical remission of major depressive episodes in iranian patients after citalopram treatment.
منابع مشابه
Serotonin Transporter Polymorphism (5-HTTLPR) and Citalopram Effectiveness in Iranian Patients with Major Depressive Disorder
OBJECTIVE Several studies have implicated the 5-HTTLPR polymorphism in treatment outcomes of selective serotonin re-uptake inhibitors in patients with major depression. The aim of this study was to examine the association between polymorphism in the serotonin transporter gene and citalopram effectiveness in Iranian patients suffering from major depressive disorder (MDD). METHODS The sample co...
متن کاملSerotonin transporter gene (5-HTT) polymorphism and major depressive disorder in patients in Bogotá, Colombia.
INTRODUCTION The 5-HTT short allele has been controversially associated with an increased risk of major depressive disorder. OBJECTIVE To determine the association of 5-HTT short allele with major depression in Bogotá, Colombia. MATERIALS AND METHODS We carried out a study of cases (n=68) matched 1:1 with controls by gender and age (±5 years). Major depression was diagnosed using the Mini...
متن کاملThe serotonin transporter polymorphism (5-HTTLPR): allelic variation and links with depressive symptoms.
BACKGROUND We compare the genotype distribution for the serotonin transporter polymorphism (5-HTTLPR) in a sample of older Taiwanese adults with samples of various racial and ethnic groups collected in other studies. We also explore interactions among sex, stressors, and 5-HTTLPR genotype on depressive symptoms in our sample. METHODS Using a nationally representative sample of 984 Taiwanese a...
متن کاملSerotonin transporter 5-HTTLPR polymorphism and response to citalopram in terminally ill cancer patients: report of twenty-one cases.
The aim of this study was to examine the effects of the SSRI antidepressant drug citalopram on anxiety, depression and mental adjustment to cancer in terminally ill cancer patients, considering also the 5-HTTLPR genetic polymorphism. A group of twenty-one consecutive patients admitted to the hospice of the Casa di Cura Pineta del Carso (Trieste, Italy) with different types of advanced cancer, w...
متن کاملThe Serotonin Transporter Polymorphism (5-HTTLPR) and Alcohol Problems in Heavy Drinkers: Moderation by Depressive Symptoms
Heavy alcohol use in young adults has been prospectively associated with a host of psychosocial and alcohol-related problems. Recent studies have supported the interaction between serotonin transporter polymorphism and adverse environmental factors, as a predictor of alcohol use and the development of alcohol dependence. The current study examined the role of depressive symptoms in combination ...
متن کاملCost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
Clinical trials have shown better efficacy of escitalopram over citalopram, and review-based economic models the cost-effectiveness of escitalopram vs. citalopram (brand and generic). No head-to-head clinical trial has, however, evaluated the cost-effectiveness of both drugs so far. The aim of this study was to assess the relative cost-effectiveness of escitalopram compared with citalopram in p...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
iranian journal of psychiatryجلد ۸، شماره ۲، صفحات ۸۶-۹۱
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023